Trial
NCT05263505
Baricitinib for the Treatment of Ocular Mucous Membrane Pemphigoid
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Washington University School of Medicine
Collaborators
Eli Lilly and Company
Condition
Mucous Membrane Pemphigoid
Intervention
Baricitinib 2 MG [Olumiant]
Why stopped
Sponsor
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-07